Altimmune (NASDAQ:ALT) Q3 2026 Earnings Call
Altimmune (NASDAQ:ALT) reports Q3 2026 results on this call. Live coverage runs here, and the full replay with transcript and chapters lands on this page after the call.
- Company
- Altimmune, Inc. (NASDAQ:ALT)
- Period
- Q3 2026 earnings call
- Date
- Thu, Nov 12, 2026, 8:30 AM ET
On 6ix: 6ix.com/event/altimmune-inc-alt-q3-2026-earnings-call
Latest news releases
- NASDAQ:ALT — Altimmune Presents Positive Late-Breaking Pemvidutide Data at AASLD The Liver Meeting® 2026 in Patients with Alcohol Use Disorder · Mon, Nov 9, 2026
- NASDAQ:ALT — Altimmune Announces Data from RECLAIM Phase 2 Trial of Pemvidutide in Alcohol Use Disorder Selected as Late-Breaking Oral Presentation at AASLD The Liver Meeting® 2026 · Thu, Nov 5, 2026